NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

Nobody calls anybody full professor. It's really strange you called your self full professor the other day.

But at least you have a better understanding as to why TLD has been delayed buy not sure what you suggested is in your post.

Anyone should realize the trial now have one primary endpoint and five other secondary endpoints which unlike a usual trial which would normally have around three endpoints including primary endpoint.

So it should be understood DCVax-L trial should take longer time to analyze than a usual phase 3 trial.

Nothing abnormal is going on at this time, not definitely withholding data as you asserts.

Investors also don't understand if DCVax-L is truly very effective, then not all endpoints should be med. For instance, if patients reacts very positively to DCVax-L injection, then pseudo-progression would most likely occurs, then the second endpoint compares PFS between the treatment arm and the placebo arm would definitely not be met.

There is added complexity so it would take longer time than usual for statisticians, the company and experts to analyze the data.

For that reason, I don't see any delay at all, but it's about time if anything goes smoothly the TLD should be announced any day now.